Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £61.45m
FEN Live PriceLast checked at - London Stock Exchange

Intraday Frenkel Topping Share Chart

AGM Statement

19 May 2015 07:00

RNS Number : 5602N
Frenkel Topping Group PLC
19 May 2015
 

19 May 2015

Frenkel Topping Group plc

("Frenkel Topping" or "the Company")

 

AGM Statement

 

Frenkel Topping (AIM:FEN), a leading provider of specialist independent financial advice on the investment of personal injury damages and clinical negligence awards, will be holding its Annual General Meeting in Manchester at 10am today. 

 

At the meeting, David Southworth, Chairman of the Frenkel Topping, will make the following statement:

 

The current year has started well, with trading in line with expectations, as the Company focused on its stated objective of growing its geographic reach.

 

Since the year-end we have added 2 fee earners, taking the total to 16, compared to 14 as at 31 December 2014. AUM has grown to approximately £640m during the first quarter, compared to £619m at the year end. As per our stated objective we expect recent hires to generate increases in AUM and recurring investment revenues as they develop their operations in 2016 and onwards.

 

We now have an established presence in Manchester, London, Birmingham, Leeds, Cardiff and Bristol. The regional expansion across England and Wales continues to develop as planned and, as previously stated, is expected to deliver accelerated growth from 2016 onwards.

 

Earlier this month we held an extremely successful Deputy Day in London, for Court of Protection specialists and experts, looking at the need to ensure freedom of choice, trust and effective decision making for clients. We will continue to host events aimed at further strengthening our relationships with advisers as we build on the progress we have made to date this year.

 

Our underlying fundamentals remain strong with a 99% client retention rate for our Investment Management Services providing high levels of revenue visibility, helping to underpin continued profitability and cash generation.

 

 

For further information:

 

Frenkel Topping Group Plc

www.frenkeltopping.co.uk

Richard Fraser, Chief Executive

Tel: 0161 886 8000

Julie Dean, Finance Director

 

 

 

Shore Capital

 

Pascal Keane / Patrick Castle

Tel: 020 7408 4090

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

About Frenkel Topping: www.frenkeltopping.co.uk

 

Frenkel Topping provides specialist independent financial advice on the investment of personal injury damages and clinical negligence awards. Frenkel Topping offers a complete service for all personal injury claims handlers, lawyers and individual clients, dealing with awards from a few thousand pounds to multi-million pound cases. The Company is a well recognised provider of expert witness reports in these cases and is then able to offer financial advice following settlement of the claim.

 

The Company's expertise includes asset protection, bespoke investment portfolios, analysis of periodical payments, Court of Protection portfolios and provision and setting up of trustee and receivership bank accounts.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMPKFDPPBKDAPD
Date   Source Headline
6th Sep 20139:26 amRNSHolding(s) in Company
5th Sep 20132:34 pmRNSDirector/PDMR Shareholding
14th Aug 20133:17 pmRNSDirector/PDMR Shareholding - Replacement
14th Aug 20139:44 amRNSDirector/PDMR Shareholding and Group EBT Purchase
6th Aug 20132:28 pmRNSExercise of options
15th Jul 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSNotice of Interim Results
29th May 201310:42 amRNSResult of AGM
29th May 20139:16 amRNSDirector/PDMR Shareholding
29th May 20137:00 amRNSAGM Statement
21st May 20134:10 pmRNSHolding(s) in Company
17th May 20137:00 amRNSHolding(s) in Company
15th May 20133:56 pmRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSPreliminary Results
3rd Apr 20132:57 pmRNSHolding(s) in Company
28th Feb 20137:00 amRNSTotal Voting Rights
12th Feb 20137:00 amRNSAcquisitions of Minority Interests in Subsidiaries
1st Feb 20134:49 pmRNSHolding(s) in Company
1st Feb 20131:54 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSNotice of Results
16th Jan 20137:00 amRNSTrading Update
30th Nov 20121:26 pmRNSHolding(s) in Company
23rd Oct 201211:23 amRNSDirector's Dealing and Group EBT Share Purchase
4th Oct 20127:00 amRNSFrenkel Topping implements new integrated platform
28th Sep 20127:00 amRNSTotal Voting Rights
10th Sep 201212:53 pmRNSDirector/PDMR Shareholding
29th Aug 201212:00 pmRNSExercise of Options
16th Jul 20127:00 amRNSInterim Results
2nd Jul 20122:07 pmRNSNotice of Interim Results
14th Jun 20126:25 pmRNSDirector/PDMR Shareholding
17th May 201211:55 amRNSResult of AGM
17th May 20127:00 amRNSAGM Statement
4th Apr 20121:42 pmRNSHolding(s) in Company
22nd Mar 20124:52 pmRNSHolding(s) in Company
20th Mar 201210:57 amRNSCalendar for 2011 Final Dividend
20th Mar 20127:00 amRNSFinal Results
22nd Feb 20124:44 pmRNSTrading Statement
12th Jan 20127:00 amRNSTrading Statement
30th Nov 20114:12 pmRNSDirector/PDMR Shareholding
23rd Nov 201111:34 amRNSDirector/PDMR Shareholding
22nd Nov 20113:01 pmRNSEmployee Benefit Trust share purchase
27th Oct 20116:11 pmRNSDirector Shareholding and Holding in Company
20th Sep 20113:41 pmRNSDirector/PDMR Shareholding
6th Sep 201112:41 pmRNSExercise of options
21st Jul 20117:00 amRNSHalf Yearly Report
1st Jul 20117:00 amRNSChange of Adviser
20th Jun 20112:20 pmRNSDirector/PDMR Shareholding
15th Jun 20115:12 pmRNSCapital Reorganisation
13th Jun 20114:00 pmRNSHolding(s) in Company
10th Jun 201112:57 pmRNSCapital Reorganisation Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.